Adenocarcinoma of the Pancreas Terminated Phase 2 Trials for Paclitaxel (DB01229)

Also known as: Pancreatic adenocarcinoma / Adenocarcinoma Pancreas / Pancreas, Adenocarcinoma / Pancreas Adenocarcinoma / Adenocarcinoma of Pancreas / Adenocarcinoma, Pancreas

IndicationStatusPhase
DBCOND0029532 (Adenocarcinoma of the Pancreas)Terminated2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT01921751High or Standard Intensity Radiation Therapy After Gemcitabine Hydrochloride and Nab-paclitaxel in Treating Patients With Pancreatic Cancer That Cannot Be Removed by SurgeryTreatment
NCT02124369Pancreatic Resectability in Cancers With Known Limited Extension (PRICKLE)Treatment